325 related articles for article (PubMed ID: 21600849)
1. Effect of earlier initiation of antiretroviral treatment and increased treatment coverage on HIV-related mortality in China: a national observational cohort study.
Zhang F; Dou Z; Ma Y; Zhang Y; Zhao Y; Zhao D; Zhou S; Bulterys M; Zhu H; Chen RY
Lancet Infect Dis; 2011 Jul; 11(7):516-24. PubMed ID: 21600849
[TBL] [Abstract][Full Text] [Related]
2. Immediate Antiretroviral Therapy Decreases Mortality Among Patients With High CD4 Counts in China: A Nationwide, Retrospective Cohort Study.
Zhao Y; Wu Z; McGoogan JM; Shi CX; Li A; Dou Z; Ma Y; Qin Q; Brookmeyer R; Detels R; Montaner JSG
Clin Infect Dis; 2018 Feb; 66(5):727-734. PubMed ID: 29069362
[TBL] [Abstract][Full Text] [Related]
3. The effect of highly active antiretroviral therapy on mortality among HIV-infected former plasma donors in China.
Zhang F; Dou Z; Yu L; Xu J; Jiao JH; Wang N; Ma Y; Zhao Y; Zhao H; Chen RY
Clin Infect Dis; 2008 Sep; 47(6):825-33. PubMed ID: 18690805
[TBL] [Abstract][Full Text] [Related]
4. Higher Risks of Virologic Failure and All-Cause Deaths Among Older People Living with HIV in Chongqing, China.
Wu G; Zhou C; Zhang X; Zhang W; Lu R; Ouyang L; Xing H; Shao Y; Ruan Y; Qian HZ
AIDS Res Hum Retroviruses; 2019; 35(11-12):1095-1102. PubMed ID: 31544479
[TBL] [Abstract][Full Text] [Related]
5. Mortality in an urban cohort of HIV-infected and at-risk drug users in the era of highly active antiretroviral therapy.
Kohli R; Lo Y; Howard AA; Buono D; Floris-Moore M; Klein RS; Schoenbaum EE
Clin Infect Dis; 2005 Sep; 41(6):864-72. PubMed ID: 16107987
[TBL] [Abstract][Full Text] [Related]
6. [Sex specific mortality in HIV/AIDS patients receiving antiretroviral therapy and risk factors in Xinjiang Uygur autonomous region].
Ni M; Chen X; Ma Y; Hu X
Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Sep; 36(9):971-5. PubMed ID: 26814865
[TBL] [Abstract][Full Text] [Related]
7. Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies.
; Sterne JA; May M; Costagliola D; de Wolf F; Phillips AN; Harris R; Funk MJ; Geskus RB; Gill J; Dabis F; Miró JM; Justice AC; Ledergerber B; Fätkenheuer G; Hogg RS; Monforte AD; Saag M; Smith C; Staszewski S; Egger M; Cole SR
Lancet; 2009 Apr; 373(9672):1352-63. PubMed ID: 19361855
[TBL] [Abstract][Full Text] [Related]
8. [Study on the mortality and risk factors among HIV/AIDS patients receiving antiretroviral therapy in Xinjiang Uygur Autonomous Region].
Ni M; Chen X; Hu X; Ma Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2014 Nov; 48(11):953-8. PubMed ID: 25582364
[TBL] [Abstract][Full Text] [Related]
9. Age in antiretroviral therapy programmes in South Africa: a retrospective, multicentre, observational cohort study.
Cornell M; Johnson LF; Schomaker M; Tanser F; Maskew M; Wood R; Prozesky H; Giddy J; Stinson K; Egger M; Boulle A; Myer L;
Lancet HIV; 2015 Sep; 2(9):e368-75. PubMed ID: 26423550
[TBL] [Abstract][Full Text] [Related]
10. Survival benefit of initiating antiretroviral therapy in HIV-infected persons in different CD4+ cell strata.
Palella FJ; Deloria-Knoll M; Chmiel JS; Moorman AC; Wood KC; Greenberg AE; Holmberg SD;
Ann Intern Med; 2003 Apr; 138(8):620-6. PubMed ID: 12693883
[TBL] [Abstract][Full Text] [Related]
11. Antiretroviral therapy to prevent HIV transmission in serodiscordant couples in China (2003-11): a national observational cohort study.
Jia Z; Mao Y; Zhang F; Ruan Y; Ma Y; Li J; Guo W; Liu E; Dou Z; Zhao Y; Wang L; Li Q; Xie P; Tang H; Han J; Jin X; Xu J; Xiong R; Zhao D; Li P; Wang X; Wang L; Qing Q; Ding Z; Chen RY; Liu Z; Shao Y
Lancet; 2013 Oct; 382(9899):1195-203. PubMed ID: 23206835
[TBL] [Abstract][Full Text] [Related]
12. Mortality in HIV-infected women, heterosexual men, and men who have sex with men in Rio de Janeiro, Brazil: an observational cohort study.
Coelho L; Grinsztejn B; Castilho JL; De Boni R; Quintana MS; Campos DP; Ribeiro SR; Pacheco AG; Veloso VG; Luz PM
Lancet HIV; 2016 Oct; 3(10):e490-8. PubMed ID: 27658875
[TBL] [Abstract][Full Text] [Related]
13. Five-year outcomes of the China National Free Antiretroviral Treatment Program.
Zhang F; Dou Z; Ma Y; Zhao Y; Liu Z; Bulterys M; Chen RY
Ann Intern Med; 2009 Aug; 151(4):241-51, W-52. PubMed ID: 19687491
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of antiretroviral treatment in HIV-infected adults: a dynamic and observational cohort study in Shenzhen, China, 2003-2014.
Huang P; Tan J; Ma W; Zheng H; Lu Y; Wang N; Peng Z; Yu R
BMJ Open; 2015 May; 5(5):e007508. PubMed ID: 26002691
[TBL] [Abstract][Full Text] [Related]
15. The effect of injecting drug use history on disease progression and death among HIV-positive individuals initiating combination antiretroviral therapy: collaborative cohort analysis.
Murray M; Hogg RS; Lima VD; May MT; Moore DM; Abgrall S; Bruyand M; D'Arminio Monforte A; Tural C; Gill MJ; Harris RJ; Reiss P; Justice A; Kirk O; Saag M; Smith CJ; Weber R; Rockstroh J; Khaykin P; Sterne JA;
HIV Med; 2012 Feb; 13(2):89-97. PubMed ID: 21819529
[TBL] [Abstract][Full Text] [Related]
16. Estimation of mortality among HIV-infected people on antiretroviral treatment in East Africa: a sampling based approach in an observational, multisite, cohort study.
Geng EH; Odeny TA; Lyamuya RE; Nakiwogga-Muwanga A; Diero L; Bwana M; Muyindike W; Braitstein P; Somi GR; Kambugu A; Bukusi EA; Wenger M; Wools-Kaloustian KK; Glidden DV; Yiannoutsos CT; Martin JN
Lancet HIV; 2015 Mar; 2(3):e107-16. PubMed ID: 26424542
[TBL] [Abstract][Full Text] [Related]
17. Incidence, risk factors and causes of death in an HIV care programme with a large proportion of injecting drug users.
Spillane H; Nicholas S; Tang Z; Szumilin E; Balkan S; Pujades-Rodriguez M
Trop Med Int Health; 2012 Oct; 17(10):1255-63. PubMed ID: 22863110
[TBL] [Abstract][Full Text] [Related]
18. Survival and causes of death among HIV-infected patients starting antiretroviral therapy in north-eastern Vietnam.
Cuong do D; Thorson A; Sönnerborg A; Hoa NP; Chuc NT; Phuc HD; Larsson M
Scand J Infect Dis; 2012 Mar; 44(3):201-8. PubMed ID: 22122590
[TBL] [Abstract][Full Text] [Related]
19. Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings.
Bedell R; Heath KV; Hogg RS; Wood E; Press N; Yip B; O'Shaughnessy MV; Montaner JS
Antivir Ther; 2003 Oct; 8(5):379-84. PubMed ID: 14640384
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of the Botswana national HIV/AIDS treatment programme from 2002 to 2010: a longitudinal analysis.
Farahani M; Vable A; Lebelonyane R; Seipone K; Anderson M; Avalos A; Chadborn T; Tilahun H; Roumis D; Moeti T; Musuka G; Busang L; Gaolathe T; Malefho KC; Marlink R
Lancet Glob Health; 2014 Jan; 2(1):e44-50. PubMed ID: 25104635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
